Weston Nichols serves as Executive at Crinetics Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Weston Nichols has executed 6 insider transactions totaling $1.6M, demonstrating a bullish approach to their equity position. Their most recent transaction on Oct 28, 2025 involved purchasing 165,667 shares valued at $1.4M.
Weston Nichols currently holds 8,963,500 shares of Crinetics Pharmaceuticals, Inc. (CRNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Weston Nichols has been a net buyer of CRNX stock. They have purchased $1.6M and sold $0 worth of shares.
Weston Nichols's most recent insider trade was on Oct 28, 2025, when they purchased 165,667 shares at $8.40 per share.
Get notified when new Form 4 filings are submitted
| $6.99 |
| Discretionary |
| Sep 12, 2025 | PASG | $138.3K | Purchase | 19,783 | $6.99 | Discretionary |
| Sep 11, 2025 | PASG | $2.3K | Purchase | 325 | $6.96 | Discretionary |
| Jun 7, 2024 | CRNX | $0 | Award | 3,400 | $N/A | Discretionary |
| Jun 16, 2023 | CRNX | $0 | Award | 6,000 | $N/A | Discretionary |